Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AATK AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77 ENSG00000181409 Apoptosis-associated tyrosine kinase 17 81117295-81166077 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009073 Supported Uncertain Mitochondria Tissue enhanced 0 cerebral cortex: 36.5;duodenum: 24.0 small intestine: 18.7 ABL1 ABL, c-ABL, JTK7, p150 ENSG00000097007 ABL proto-oncogene 1, non-receptor tyrosine kinase 9 130713946-130887675 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002686, HPA027251, HPA027280, HPA028409 Supported Validated Nucleoplasm
Nuclear bodies Expressed in all parathyroid gland: 82.2 ABL2 ABLL, ARG ENSG00000143322 ABL proto-oncogene 2, non-receptor tyrosine kinase 1 179099327-179229684 Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001866, CAB017106 Uncertain Supported Nucleoplasm Mixed gallbladder: 20.3 ALK CD246 ENSG00000171094 Anaplastic lymphoma receptor tyrosine kinase 2 29192774-29921566 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010694 Approved Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 3.5;testis: 2.3 adrenal gland: 0.9 AXL ARK, JTK11, Tyro7, UFO ENSG00000167601 AXL receptor tyrosine kinase 19 41219203-41261766 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032501, HPA037422, HPA037423 Uncertain Approved Intermediate filaments Expressed in all smooth muscle: 54.0 BLK MGC10442 ENSG00000136573 BLK proto-oncogene, Src family tyrosine kinase 8 11494001-11564604 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005093 Approved Group enriched 10 appendix: 22.9;lymph node: 61.9;spleen: 41.3;tonsil: 54.0 urinary bladder: 4.5 BMX ETK, PSCTK3 ENSG00000102010 BMX non-receptor tyrosine kinase X 15464246-15556529 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001048, CAB032495 Supported Supported Nucleoplasm
Plasma membrane Tissue enriched 18 epididymis: 122.9 placenta: 6.9 BTK AGMX1, ATK, IMD1, PSCTK1, XLA ENSG00000010671 Bruton agammaglobulinemia tyrosine kinase X 101349447-101390796 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001198, HPA002028, CAB016689 Supported Supported Vesicles Tissue enhanced 0 lymph node: 66.0;tonsil: 73.6 spleen: 53.6 CSF1R C-FMS, CD115, CSFR, FMS ENSG00000182578 Colony stimulating factor 1 receptor 5 150053291-150113372 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008970, HPA012323 Uncertain Supported Vesicles
Plasma membrane Mixed spleen: 150.2 CSK ENSG00000103653 C-src tyrosine kinase 15 74782057-74803198 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011203, HPA026488, HPA028425 Approved Approved Vesicles
Cytosol Expressed in all lymph node: 197.7 DDR1 CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6 ENSG00000204580 Discoidin domain receptor tyrosine kinase 1 6 30876421-30900156 CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010162, CAB025656, HPA057194 Approved Approved Nucleoplasm
Cell Junctions Mixed cerebral cortex: 51.7 DDR2 NTRKR3, TKT, TYRO10 ENSG00000162733 Discoidin domain receptor tyrosine kinase 2 1 162631373-162787400 CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070112 Supported Plasma membrane
Actin filaments Mixed adrenal gland: 94.0 EGFR ERBB, ERBB1 ENSG00000146648 Epidermal growth factor receptor 7 55019021-55256620 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000035, HPA001200, HPA018530, CAB068186, CAB073534 Supported Validated Plasma membrane Tissue enhanced 0 placenta: 97.3 skin: 58.9 EPHA1 EPH, EPHT, EPHT1 ENSG00000146904 EPH receptor A1 7 143390289-143408892 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026144 Approved Tissue enriched 24 parathyroid gland: 861.4 esophagus: 36.4 EPHA10 FLJ16103, FLJ33655 ENSG00000183317 EPH receptor A10 1 37713880-37765133 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027497 Uncertain Tissue enhanced 0 testis: 20.4 colon: 8.1 EPHA2 ECK ENSG00000142627 EPH receptor A2 1 16124337-16156087 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066055 Uncertain Vesicles Tissue enhanced 0 esophagus: 87.1 gallbladder: 44.7 EPHA3 ETK, ETK1, HEK, HEK4, TYRO4 ENSG00000044524 EPH receptor A3 3 89107524-89482134 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010462 Approved Uncertain Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 prostate: 49.0 gallbladder: 29.9 EPHA4 Hek8, TYRO1 ENSG00000116106 EPH receptor A4 2 221418027-221574202 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB028368 Supported Tissue enhanced 0 cerebral cortex: 41.8 testis: 22.3 EPHA5 CEK7, EHK1, Hek7, TYRO4 ENSG00000145242 EPH receptor A5 4 65319563-65670495 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 5 cerebral cortex: 18.0 cervix: 3.3 EPHA6 FLJ35246 ENSG00000080224 EPH receptor A6 3 96814581-97752460 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA007397, HPA058047 Uncertain Validated Nucleoplasm Tissue enhanced 0 ovary: 7.7;testis: 15.1 cerebral cortex: 3.6 EPHA7 Hek11 ENSG00000135333 EPH receptor A7 6 93240020-93419547 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010496 Uncertain Tissue enriched 13 parathyroid gland: 250.5 prostate: 19.4 EPHA8 EEK, Hek3 ENSG00000070886 EPH receptor A8 1 22563564-22603594 Cancer-related genes, Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009660, HPA031433 Uncertain Tissue enhanced 0 adrenal gland: 4.9;spleen: 2.7;testis: 1.9 cerebral cortex: 1.3 EPHB1 EPHT2, Hek6 ENSG00000154928 EPH receptor B1 3 134597801-135260467 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067740 Approved Approved Endoplasmic reticulum
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 23.7;testis: 22.9 thyroid gland: 12.0 EPHB2 DRT, EPHT3, ERK, Hek5, Tyro5 ENSG00000133216 EPH receptor B2 1 22710839-22921500 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013647, HPA071200 Approved Supported Nucleus
Plasma membrane Mixed rectum: 27.8 EPHB3 ETK2, Hek2, Tyro6 ENSG00000182580 EPH receptor B3 3 184561784-184582409 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007698, HPA008184, CAB034350 Approved Tissue enhanced 0 skin: 45.4 stomach: 17.9 EPHB4 HTK, Tyro11 ENSG00000196411 EPH receptor B4 7 100802565-100827521 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013537 Uncertain Expressed in all placenta: 50.3 ERBB2 CD340, HER-2, HER2, NEU, NGL ENSG00000141736 Erb-b2 receptor tyrosine kinase 2 17 39687914-39730426 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555 Approved Supported Plasma membrane
Cytosol Expressed in all parathyroid gland: 122.9 ERBB3 HER3, LCCS2 ENSG00000065361 Erb-b2 receptor tyrosine kinase 3 12 56079857-56103505 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025331, HPA045396 Uncertain Approved Plasma membrane
Actin filaments Mixed small intestine: 88.5 ERBB4 ALS19, HER4 ENSG00000178568 Erb-b2 receptor tyrosine kinase 4 2 211375717-212538841 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB000276, HPA012016, CAB025522 Approved Tissue enhanced 0 fallopian tube: 17.6 cerebral cortex: 7.6 FER PPP1R74, TYK3 ENSG00000151422 Fer (fps/fes related) tyrosine kinase 5 108747822-109196841 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007641, CAB022464 Approved Supported Cytosol Mixed parathyroid gland: 19.2 FES FPS ENSG00000182511 FES proto-oncogene, tyrosine kinase 15 90883695-90895776 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001376 Approved Approved Nucleus
Vesicles
Cytosol Expressed in all spleen: 98.1 FGFR1 BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM ENSG00000077782 Fibroblast growth factor receptor 1 8 38411138-38468834 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033614, HPA056402, HPA076274 Approved Approved Nucleoli Expressed in all gallbladder: 109.6 FGFR2 BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 ENSG00000066468 Fibroblast growth factor receptor 2 10 121478334-121598458 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010886, HPA035305, HPA056562 Uncertain Approved Vesicles Mixed skin: 97.5 FGFR3 ACH, CD333, CEK2, JTK4 ENSG00000068078 Fibroblast growth factor receptor 3 4 1793307-1808872 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004231, HPA067204 Supported Supported Endoplasmic reticulum Tissue enriched 7 skin: 334.6 cerebral cortex: 49.7 FGFR4 CD334, JTK2 ENSG00000160867 Fibroblast growth factor receptor 4 5 177086886-177098144 Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005196, HPA027273, HPA027369, HPA028251 Approved Tissue enhanced 0 lung: 39.1 duodenum: 22.0 FGR c-fgr, p55c-fgr, SRC2 ENSG00000000938 FGR proto-oncogene, Src family tyrosine kinase 1 27612064-27635277 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002024 Supported Approved Plasma membrane
Aggresome Tissue enhanced 0 appendix: 87.8;bone marrow: 137.2;spleen: 92.1 lung: 56.3 FLT1 FLT, VEGFR1 ENSG00000102755 Fms-related tyrosine kinase 1 13 28300344-28495128 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011740, HPA014290, CAB068189, CAB068190 Supported Supported Plasma membrane
Actin filaments Tissue enriched 8 placenta: 617.5 thyroid gland: 81.7 FLT3 CD135, FLK2, STK1 ENSG00000122025 Fms-related tyrosine kinase 3 13 28003274-28100592 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047539 Approved Endoplasmic reticulum Tissue enhanced 0 lymph node: 7.1;spleen: 7.8 appendix: 4.0 FLT4 PCL, VEGFR3 ENSG00000037280 Fms-related tyrosine kinase 4 5 180601506-180649624 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000099 Supported Nuclear speckles
Plasma membrane
Cell Junctions Mixed spleen: 18.6 FRK GTK, PTK5, RAK ENSG00000111816 Fyn-related Src family tyrosine kinase 6 115931149-116060758 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025217, HPA057484 Approved Supported Nucleoplasm
Cytosol Mixed kidney: 10.4 FYN MGC45350, SLK, SYN ENSG00000010810 FYN proto-oncogene, Src family tyrosine kinase 6 111660332-111873452 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005034, CAB018387, HPA023887, HPA063770 Approved Validated Plasma membrane
Cytosol Expressed in all cerebral cortex: 166.6 HCK JTK9 ENSG00000101336 HCK proto-oncogene, Src family tyrosine kinase 20 32052188-32101856 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005195, HPA063768 Approved Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 appendix: 142.6;spleen: 108.6 lung: 67.5 IGF1R CD221, IGFIR, IGFR, JTK13, MGC18216 ENSG00000140443 Insulin-like growth factor 1 receptor 15 98648971-98964530 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010268, HPA045563 Uncertain Uncertain Vesicles Mixed prostate: 24.7 INSR CD220 ENSG00000171105 Insulin receptor 19 7112255-7294034 CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036302, HPA036303 Uncertain Supported Vesicles Expressed in all spleen: 35.4 INSRR IRR ENSG00000027644 Insulin receptor-related receptor 1 156840063-156859018 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA025285 Uncertain Tissue enhanced 0 adrenal gland: 1.8;kidney: 1.4;testis: 2.2 prostate: 0.6 ITK EMT, LYK, PSCTK2 ENSG00000113263 IL2-inducible T-cell kinase 5 157142933-157255191 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 appendix: 20.9;lymph node: 33.6;tonsil: 23.0 spleen: 14.0 JAK1 JAK1A, JAK1B, JTK3 ENSG00000162434 Janus kinase 1 1 64833229-64966504 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013088 Approved Expressed in all lymph node: 117.1 JAK2 JTK10 ENSG00000096968 Janus kinase 2 9 4985033-5128183 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013089, HPA040820, HPA043870 Approved Supported Nucleoplasm
Plasma membrane
Focal adhesion sites Mixed appendix: 25.4 JAK3 JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK ENSG00000105639 Janus kinase 3 19 17824780-17848071 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070314 Supported Approved Cytosol Tissue enhanced 0 appendix: 49.9;lymph node: 47.2 tonsil: 28.2 KDR CD309, FLK1, VEGFR, VEGFR2 ENSG00000128052 Kinase insert domain receptor 4 55078477-55125589 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004028 Approved Supported Plasma membrane Tissue enhanced 0 placenta: 118.2 thyroid gland: 54.5 KIT C-Kit, CD117, PBT, SCFR ENSG00000157404 V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 4 54657918-54740715 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003288, HPA004471, CAB068253, CAB072867, HPA073252 Supported Supported Plasma membrane Tissue enhanced 0 breast: 133.8 thyroid gland: 78.4 LCK ENSG00000182866 LCK proto-oncogene, Src family tyrosine kinase 1 32251239-32286165 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003494, CAB003816 Supported Approved Golgi apparatus Tissue enhanced 0 appendix: 68.8;lymph node: 127.7;tonsil: 75.1 spleen: 55.2 LMTK2 AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100 ENSG00000164715 Lemur tyrosine kinase 2 7 98106885-98209633 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010657, HPA041836 Uncertain Approved Nuclear speckles
Plasma membrane
Microtubule organizing center
Cytosol Expressed in all cerebral cortex: 28.0 LMTK3 KIAA1883, LMR3, PPP1R101, TYKLM3 ENSG00000142235 Lemur tyrosine kinase 3 19 48485271-48513189 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040203 Approved Nucleoplasm
Cell Junctions Group enriched 5 cerebral cortex: 20.4;parathyroid gland: 4.8 duodenum: 2.3 LTK TYK1 ENSG00000062524 Leukocyte receptor tyrosine kinase 15 41503638-41513887 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA059545 Uncertain Approved Vesicles Mixed placenta: 15.1 LYN JTK8 ENSG00000254087 LYN proto-oncogene, Src family tyrosine kinase 8 55879813-56014168 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001231, CAB004492 Supported Supported Golgi apparatus
Vesicles
Plasma membrane Tissue enhanced 0 spleen: 163.6 appendix: 133.8 MATK CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101 ENSG00000007264 Megakaryocyte-associated tyrosine kinase 19 3777970-3802129 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004847 Approved Tissue enhanced 0 cerebral cortex: 22.1 spleen: 20.2 MERTK c-Eyk, mer, RP38, Tyro12 ENSG00000153208 MER proto-oncogene, tyrosine kinase 2 111898479-112029561 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036196, HPA075622 Approved Approved Endoplasmic reticulum
Plasma membrane
Cytosol Mixed adrenal gland: 77.4 MET DFNB97, HGFR, RCCP2 ENSG00000105976 MET proto-oncogene, receptor tyrosine kinase 7 116672390-116798386 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005282, CAB018577, HPA055607 Uncertain Supported Plasma membrane
Cytosol Mixed placenta: 38.7 MST1R CD136, CDw136, PTK8, RON ENSG00000164078 Macrophage stimulating 1 receptor 3 49887002-49903873 CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007657, HPA008180, CAB008972 Approved Approved Cytosol Tissue enhanced 0 skin: 69.4 stomach: 37.4 MUSK ENSG00000030304 Muscle, skeletal, receptor tyrosine kinase 9 110668771-110801620 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed testis: 3.0 NTRK1 MTC, TRK, TRKA ENSG00000198400 Neurotrophic tyrosine kinase, receptor, type 1 1 156815640-156881850 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004606, HPA035799, HPA076570 Approved Uncertain Vesicles
Cytosol Tissue enriched 6 adrenal gland: 9.6 testis: 1.6 NTRK2 TRKB ENSG00000148053 Neurotrophic tyrosine kinase, receptor, type 2 9 84668551-85027070 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007637 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 441.0;thyroid gland: 214.8 breast: 81.9 NTRK3 TRKC ENSG00000140538 Neurotrophic tyrosine kinase, receptor, type 3 15 87859751-88256768 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009233, HPA027484, HPA048065 Supported Supported Nuclear membrane
Nucleoli Tissue enhanced 0 cerebral cortex: 39.7 testis: 15.2 PDGFRA CD140a, GAS9, PDGFR2 ENSG00000134853 Platelet-derived growth factor receptor, alpha polypeptide 4 54229097-54298247 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004947, CAB018143 Supported Supported Nucleus
Plasma membrane
Cell Junctions Expressed in all ovary: 222.0 PDGFRB CD140b, JTK12, PDGFR, PDGFR1 ENSG00000113721 Platelet-derived growth factor receptor, beta polypeptide 5 150113837-150155872 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB003842, CAB018144, HPA028499 Approved Approved Vesicles
Cytosol Mixed gallbladder: 194.6 PTK2 FADK, FAK, FAK1, PPP1R71 ENSG00000169398 Protein tyrosine kinase 2 8 140657900-141002216 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001842, CAB004036, HPA029671 Approved Supported Vesicles
Focal adhesion sites
Cytosol Expressed in all placenta: 106.5 PTK2B CADTK, CAKB, FAK2, PTK, PYK2, RAFTK ENSG00000120899 Protein tyrosine kinase 2 beta 8 27311482-27459391 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003850, HPA026091, HPA026276 Approved Validated Plasma membrane
Cytosol Expressed in all lymph node: 100.2 PTK6 BRK ENSG00000101213 Protein tyrosine kinase 6 20 63528001-63537370 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032952, HPA036070, HPA036071 Approved Supported Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol Tissue enhanced 0 esophagus: 61.2;skin: 60.6 duodenum: 30.0 PTK7 CCK4 ENSG00000112655 Protein tyrosine kinase 7 (inactive) 6 43076268-43161719 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003222 Approved Mixed endometrium: 117.0 RET CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51 ENSG00000165731 Ret proto-oncogene 10 43077027-43130351 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002581, HPA008356, HPA008495, CAB018342 Approved Supported Supported Vesicles
Plasma membrane
Cytosol Tissue enriched 5 parathyroid gland: 146.8 adrenal gland: 29.2 ROR1 NTRKR1 ENSG00000185483 Receptor tyrosine kinase-like orphan receptor 1 1 63774022-64181498 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057016 Uncertain Microtubules
Cytokinetic bridge Tissue enhanced 0 parathyroid gland: 51.2 endometrium: 12.1 ROR2 BDB, BDB1, NTRKR2 ENSG00000169071 Receptor tyrosine kinase-like orphan receptor 2 9 91563091-91950162 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021868 Uncertain Tissue enhanced 0 parathyroid gland: 34.5 endometrium: 21.3 ROS1 c-ros-1, MCF3, ROS ENSG00000047936 ROS proto-oncogene 1 , receptor tyrosine kinase 6 117288300-117425855 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049098, HPA072424 Uncertain Approved Vesicles Group enriched 18 epididymis: 69.7;lung: 47.3 seminal vesicle: 3.2 SRC ASV, c-src, SRC1 ENSG00000197122 SRC proto-oncogene, non-receptor tyrosine kinase 20 37344685-37406050 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004023, HPA030875 Approved Validated Plasma membrane
Cytosol Mixed small intestine: 43.7 SRMS C20orf148, dJ697K14.1, SRM ENSG00000125508 Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites 20 63540810-63547504 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB044668, CAB044669, HPA073987 Uncertain Approved Intermediate filaments
Actin filaments
Cytosol Mixed stomach: 1.5 STYK1 DKFZp761P1010, NOK, SuRTK106 ENSG00000060140 Serine/threonine/tyrosine kinase 1 12 10618939-10674318 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA040468, HPA048569 Uncertain Approved Nucleus
Plasma membrane Mixed rectum: 17.8 SYK ENSG00000165025 Spleen tyrosine kinase 9 90801787-90898549 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001384, CAB007773 Supported Approved Vesicles
Plasma membrane
Cytosol Mixed parathyroid gland: 94.2 TEC PSCTK4 ENSG00000135605 Tec protein tyrosine kinase 4 48135783-48269864 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005733, HPA024657 Approved Supported Plasma membrane Mixed epididymis: 4.9 TEK CD202b, TIE-2, TIE2, VMCM, VMCM1 ENSG00000120156 TEK tyrosine kinase, endothelial 9 27109141-27230175 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010359, HPA073265 Approved Supported Plasma membrane
Microtubule organizing center Tissue enhanced 0 placenta: 65.3 lung: 42.7 TIE1 JTK14, TIE ENSG00000066056 Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 1 43300993-43323108 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045769 Approved Vesicles Tissue enhanced 0 placenta: 70.1 lung: 40.1 TNK1 ENSG00000174292 Tyrosine kinase, non-receptor, 1 17 7380534-7389774 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012065, HPA056452 Uncertain Approved Cell Junctions Mixed skin: 10.3 TNK2 ACK, ACK1, p21cdc42Hs ENSG00000061938 Tyrosine kinase, non-receptor, 2 3 195863364-195911945 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041954 Approved Approved Cytosol Expressed in all cerebral cortex: 109.8 TXK BTKL, PSCTK5, PTK4, RLK, TKL ENSG00000074966 TXK tyrosine kinase 4 48066393-48134256 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062482 Approved Vesicles Tissue enhanced 0 lymph node: 18.1 spleen: 14.9 TYK2 JTK1 ENSG00000105397 Tyrosine kinase 2 19 10350529-10380676 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005157 Uncertain Approved Cytosol Expressed in all spleen: 101.6 TYRO3 Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif ENSG00000092445 TYRO3 protein tyrosine kinase 15 41557675-41583586 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071245 Approved Tissue enhanced 0 cerebral cortex: 67.6;ovary: 61.4 testis: 36.9 YES1 c-yes, HsT441, Yes ENSG00000176105 YES proto-oncogene 1, Src family tyrosine kinase 18 721588-812546 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004370, HPA026480 Approved Supported Plasma membrane
Cytosol Expressed in all placenta: 61.6 ZAP70 SRK, STD, ZAP-70 ENSG00000115085 Zeta-chain (TCR) associated protein kinase 70kDa 2 97713560-97739862 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002625, HPA003134 Supported Tissue enhanced 0 appendix: 37.7;lymph node: 65.2;spleen: 38.3 tonsil: 16.9